MedPath

Plaxomib

Brand Name: Plaxomib

Generic Name: Moxifloxacin (as Hydrochloride)

Active
Registration Number

DRP-13374

Dosage Form

Ophthalmic Solution

Issuance Date

February 8, 2023

Expiry Date

February 8, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5 mg/mL (0.5% 0.5% w/v)
PackagingLDPE Dropper Bottle Sealed with White HDPE Screw Cap x 5 mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Moxifloxacin (as Hydrochloride)Active
Monograph: Moxifloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform